Talis Biomedical Corp. (TLIS)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Company performance

Current Price

as of Jan 07, 2025

$1.86

P/E Ratio

N/A

Market Cap

$58.94M

Jan 23, 2024Feb 27, 2024Apr 1, 2024May 2, 2024Jun 5, 2024Jul 9, 2024Aug 8, 2024Sep 12, 2024Oct 16, 2024Nov 19, 2024Jan 3, 2025$0.00$10.00
  • DHC
Description

Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Chicago, IL.

Metrics

Overview

  • HQChicago, IL
  • SectorHealth Technology
  • IndustryMedical Specialties
  • TickerTLIS
  • Price$1.86+3.91%

Trading Information

  • Market cap$58.94M
  • Float5.28%
  • Average Daily Volume (1m)3,753
  • Average Daily Volume (3m)4,460
  • EPS-$28.02

Company

  • Revenue$0.30M
  • Rev growth (1yr)-100.00%
  • Net income-$8.85M
  • Gross marginN/A
  • EBITDA marginN/A
  • EBITDA-$8.49M
  • EV-$25.28M
  • EV/Revenue-84.26
  • P/EN/A
  • P/S11.30
  • P/B1.21
Documents